Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study

Basal cell carcinoma is the most prevalent cancer in Caucasians worldwide. The aim of this study was to examine the overall risk of melanoma among patients diagnosed with basal cell carcinoma. This population-based retrospective cohort study included data from January 2010 to December 2018 from the...

Full description

Bibliographic Details
Main Authors: Daniella Kushnir-Grinbaum, Judit Krausz, Nader Rahal, Liat Apel-Sarid, Michael Ziv
Format: Article
Language:English
Published: Medical Journals Sweden 2023-01-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access:https://medicaljournalssweden.se/actadv/article/view/4402
_version_ 1797961195374772224
author Daniella Kushnir-Grinbaum
Judit Krausz
Nader Rahal
Liat Apel-Sarid
Michael Ziv
author_facet Daniella Kushnir-Grinbaum
Judit Krausz
Nader Rahal
Liat Apel-Sarid
Michael Ziv
author_sort Daniella Kushnir-Grinbaum
collection DOAJ
description Basal cell carcinoma is the most prevalent cancer in Caucasians worldwide. The aim of this study was to examine the overall risk of melanoma among patients diagnosed with basal cell carcinoma. This population-based retrospective cohort study included data from January 2010 to December 2018 from the databases of the Clalit Health Maintenance Organization and 2 major pathology laboratories in North District, Israel. The incidence and hazard ratio of melanoma in patients with a diagnosis of basal cell carcinoma were determined. Of 466,700 participants, 51% were women and the mean (standard deviation) follow-up was 6.7 (2.9; range 1–9) years. A total of 3,338 patients were diagnosed with basal cell carcinoma during the study period, 82 of whom subsequently developed melanoma. Patients with basal cell carcinoma had a significantly higher incidence of melanoma than patients without basal cell carcinoma (2.46% vs 0.37%; p < 0.0001). Univariate Cox regression analysis revealed a hazard ratio of 6.6 (95% confidence interval: 3.6–12.1; p < 0.0001) for melanoma in patients with a diagnosis of basal cell carcinoma. In conclusion, a diagnosis of basal cell carcinoma confers a significant risk of melanoma. 
first_indexed 2024-04-11T00:55:19Z
format Article
id doaj.art-4a09c5cbf8ff4d9eaae30621fb1715b2
institution Directory Open Access Journal
issn 0001-5555
1651-2057
language English
last_indexed 2024-04-11T00:55:19Z
publishDate 2023-01-01
publisher Medical Journals Sweden
record_format Article
series Acta Dermato-Venereologica
spelling doaj.art-4a09c5cbf8ff4d9eaae30621fb1715b22023-01-05T05:35:05ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572023-01-0110310.2340/actadv.v103.4402Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort StudyDaniella Kushnir-Grinbaum0Judit Krausz1Nader Rahal2Liat Apel-Sarid3Michael Ziv4Dermatology Department, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula 1834111, IsraelPathology Department, Emek Medical Center, Afula, IsraelDermatology Department, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula 1834111, Israel; Clalit Health Maintenance Service North District, Israel Patho-Lab Diagnostics, Assuta Medical Centers, IsraelDermatology Department, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula 1834111, IsraelBasal cell carcinoma is the most prevalent cancer in Caucasians worldwide. The aim of this study was to examine the overall risk of melanoma among patients diagnosed with basal cell carcinoma. This population-based retrospective cohort study included data from January 2010 to December 2018 from the databases of the Clalit Health Maintenance Organization and 2 major pathology laboratories in North District, Israel. The incidence and hazard ratio of melanoma in patients with a diagnosis of basal cell carcinoma were determined. Of 466,700 participants, 51% were women and the mean (standard deviation) follow-up was 6.7 (2.9; range 1–9) years. A total of 3,338 patients were diagnosed with basal cell carcinoma during the study period, 82 of whom subsequently developed melanoma. Patients with basal cell carcinoma had a significantly higher incidence of melanoma than patients without basal cell carcinoma (2.46% vs 0.37%; p < 0.0001). Univariate Cox regression analysis revealed a hazard ratio of 6.6 (95% confidence interval: 3.6–12.1; p < 0.0001) for melanoma in patients with a diagnosis of basal cell carcinoma. In conclusion, a diagnosis of basal cell carcinoma confers a significant risk of melanoma.  https://medicaljournalssweden.se/actadv/article/view/4402basal cell carcinomamelanomamalignant melanomaskin cancerrisk factorcohort study
spellingShingle Daniella Kushnir-Grinbaum
Judit Krausz
Nader Rahal
Liat Apel-Sarid
Michael Ziv
Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study
Acta Dermato-Venereologica
basal cell carcinoma
melanoma
malignant melanoma
skin cancer
risk factor
cohort study
title Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study
title_full Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study
title_fullStr Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study
title_full_unstemmed Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study
title_short Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study
title_sort risk of melanoma in patients with basal cell carcinoma a population based cohort study
topic basal cell carcinoma
melanoma
malignant melanoma
skin cancer
risk factor
cohort study
url https://medicaljournalssweden.se/actadv/article/view/4402
work_keys_str_mv AT daniellakushnirgrinbaum riskofmelanomainpatientswithbasalcellcarcinomaapopulationbasedcohortstudy
AT juditkrausz riskofmelanomainpatientswithbasalcellcarcinomaapopulationbasedcohortstudy
AT naderrahal riskofmelanomainpatientswithbasalcellcarcinomaapopulationbasedcohortstudy
AT liatapelsarid riskofmelanomainpatientswithbasalcellcarcinomaapopulationbasedcohortstudy
AT michaelziv riskofmelanomainpatientswithbasalcellcarcinomaapopulationbasedcohortstudy